Valuation DaShenLin Pharmaceutical Group Co., Ltd.

Stocks

End-of-day quote Shanghai S.E. 04/09/2026			5-day change	1st Jan Change
18.79 ^CNY	+1.51%		+3.53%	+6.64%

09-02	Jefferies Adjusts DaShenLin Pharmaceutical Group's Price Target to 15 Yuan From 12 Yuan, Keeps at Underperform	MT
08-24	DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	33,307	37,585	28,359	17,151	20,066	21,399	-	-
Change	-	12.85%	-24.55%	-39.52%	17%	6.64%	-	-
Enterprise Value (EV) ¹	32,838	36,233	27,369	15,778	16,831	18,059	17,639	17,343
Change	-	10.34%	-24.46%	-42.35%	6.67%	7.3%	-2.33%	-1.67%
P/E	42.1x	36.3x	24.2x	18.6x	16.3x	14.4x	12.5x	11x
PBR	6.3x	6.24x	4.16x	2.49x	2.72x	2.73x	2.5x	2.33x
PEG	-	1.2x	1.8x	-0.9x	0.5x	0.7x	0.8x	0.8x
Capitalization / Revenue	1.99x	1.77x	1.16x	0.65x	0.73x	0.72x	0.66x	0.6x
EV / Revenue	1.96x	1.71x	1.12x	0.6x	0.61x	0.61x	0.54x	0.48x
EV / EBITDA	13.6x	19.2x	12.9x	4.65x	4.39x	4.72x	4.2x	3.73x
EV / EBIT	31.6x	25.5x	16.8x	10.5x	8.26x	7.77x	6.67x	5.79x
EV / FCF	117x	13.1x	19.7x	9.51x	3.44x	10.5x	6.31x	5.34x
FCF Yield	0.86%	7.61%	5.09%	10.5%	29.1%	9.55%	15.8%	18.7%
Dividend per Share ²	0.3472	0.5	0.31	0.31	0.49	0.9418	1.043	1.222
Rate of return	1.19%	1.52%	1.24%	2.06%	2.78%	5.01%	5.55%	6.5%
EPS ²	0.6944	0.9083	1.03	0.81	1.08	1.304	1.5	1.701
Distribution rate	50%	55%	30.1%	38.3%	45.4%	72.2%	69.5%	71.8%
Net sales ¹	16,759	21,248	24,531	26,497	27,502	29,540	32,521	35,823
EBITDA ¹	2,408	1,883	2,119	3,395	3,833	3,828	4,204	4,651
EBIT ¹	1,041	1,421	1,632	1,501	2,038	2,324	2,643	2,997
Net income ¹	791.2	1,036	1,166	914.8	1,235	1,486	1,711	1,937
Net Debt ¹	-469.2	-1,352	-989.8	-1,373	-3,236	-3,340	-3,760	-4,056
Reference price ²	29.24	33.00	24.90	15.06	17.62	18.79	18.79	18.79
Nbr of stocks (in thousands)	1,138,968	1,138,947	1,138,902	1,138,848	1,138,848	1,138,848	-	-
Announcement Date	27/04/22	27/04/23	28/04/24	25/04/25	23/04/26	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	14.41x	0.61x	4.72x	5.01%	3.19B
JD HEALTH INTERNATIONAL INC.	16.91x	0.69x	10.24x	-.--%	15.07B
MATSUKIYOCOCOKARA & CO.	16.81x	0.76x	7.89x	2.22%	6.55B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	20.89x	0.8x	13.4x	1.07%	6.47B
YIFENG PHARMACY CHAIN CO., LTD.	14.69x	0.9x	6.23x	2.88%	4.14B
NAHDI MEDICAL COMPANY	14.27x	1.23x	7.5x	5.64%	3.17B
CLICKS GROUP LIMITED	13.8x	0.83x	6.23x	4.67%	2.94B
GUARDIAN PHARMACY SERVICES, INC.	33.21x	-	-	-	2.58B
Average	18.12x	0.83x	8.03x	3.07%	5.51B
Weighted average by Cap.	17.65x	0.78x	9.05x	1.95%